Intentions to receive a potentially available Lyme disease vaccine in an urban sample

Abstract

Objectives:The only human Lyme disease vaccine of LYMErix was voluntarily removed from the market in the United States in 2002 for a number of reasons. A new human Lyme disease vaccine is currently being developed. We would like any future approved human Lyme disease vaccine to be of interest and marketable to consumers. Methods: We surveyed 714 participants to determine variables associated with intentions to receive a Lyme disease vaccine. Predictor variables included demographics, protection motivational theory, Lyme disease knowledge, Lyme disease preventive behaviors, beliefs and perceived health. Results: We found in multivariate linear regression analyses that Asian/Asian American race/ ethnicity (p < 0.001), South Asian race/ethnicity (p = 0.01) and coping appraisal variables of response efficacy (p < 0.001) and self-efficacy (p < 0.001) were each significantly associated with increased intentions. The belief that vaccines are typically not safe was significantly associated with decreased intentions (p = 0.03). Conclusions: Asian/Asian American and South Asian race/ethnicities have a strong interest in receiving a Lyme disease vaccine. Although pharmaceutical companies may benefit by advertising a Lyme disease vaccine to Asian/Asian Americans and South Asians, marketers need to address and use approaches to interest those from other race/ethnicities. Also, marketers need to address the erroneous belief that vaccines are typically not safe in order to interest those with such beliefs to use a Lyme disease vaccine.

Predicting Covid-19 Vaccination Intention: The Role of Health Belief Model of Muslim Societies in Yogyakarta

“…Vaksin adalah tonggak penting bagi peningkatan kesehatan masyarakat (Urias, 2017) dan idealnya berkontribusi secara efektif dan efisien terhadap penurunan yang kuat untuk penyakit menular yang dicegah dengan vaksinasi (Fogel & Kusz, 2016;Zhang & Fisk, 2021). Terlebih lagi disituasi seperti pandemi covid-19 seperti saat ini yang tidak ada obat profilaksis yang mujarab serta sedikitnya perawatan (Hodgson et al, 2021).…”

Predictors of Willingness to Receive the COVID-19 Vaccine after Emergency Use Authorization: The Role of Coping Appraisal

“…However, in the early stage of the vaccine rollout, there have been concerns about the vaccination rates. For effective vaccines, the inadequate use of the vaccine can become a public health issue, as declining vaccination rates at the population level could lead to an increase in morbidity and mortality from diseases that are vaccine-preventable [ 4 , 5 ]. Therefore, understanding the determinants of the willingness to obtain the COVID-19 vaccine is necessary, especially in the early stage of vaccine approval, to inform future vaccination programs and campaigns and to increase the uptake of the COVID-19 vaccine in China.…”